Development of an Effective Single-Dose PCV2/CSFV Bivalent Subunit Vaccine Against Classical Swine Fever Virus and Porcine Circovirus Type 2

<b>Background/Objectives</b>: Porcine Circovirus Type 2 (PCV2) impairs pigs’ immune systems and increases susceptibility to co-infections, including Classical Swine Fever (CSF), a highly contagious disease listed by the World Organisation for Animal Health (WOAH) as notifiable. Therefore...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu-Chieh Chen, Wen-Bin Chung, Hso-Chi Chaung, Yen-Li Huang, Chi-Chih Chen, Guan-Ming Ke
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/7/736
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839615110152192000
author Yu-Chieh Chen
Wen-Bin Chung
Hso-Chi Chaung
Yen-Li Huang
Chi-Chih Chen
Guan-Ming Ke
author_facet Yu-Chieh Chen
Wen-Bin Chung
Hso-Chi Chaung
Yen-Li Huang
Chi-Chih Chen
Guan-Ming Ke
author_sort Yu-Chieh Chen
collection DOAJ
description <b>Background/Objectives</b>: Porcine Circovirus Type 2 (PCV2) impairs pigs’ immune systems and increases susceptibility to co-infections, including Classical Swine Fever (CSF), a highly contagious disease listed by the World Organisation for Animal Health (WOAH) as notifiable. Therefore, swine operations in CSF-endemic regions are encouraged to immunize piglets with both PCV2 and CSFV vaccinations. Currently, there is no commercially available bivalent vaccine for PCV2/CSFV. <b>Methods</b>: In this study, a total of twenty 4-week-old SPF pigs were administered our formulated PCV2/CSFV bivalent subunit vaccine, containing soluble CSFV-E2 (50 µg) and PCV2-ORF2 (100 µg) antigens with a porcine-specific CpG adjuvant. After 4 weeks of vaccination, all pigs were evaluated for efficacy against PCV2 and CSFV. <b>Results</b>: Pigs were only immunized once and showed significantly increased neutralizing or ELISA antibody titers against both viruses four weeks post-vaccination. After viral challenges, vaccinated pigs displayed no clinical signs or lesions and had markedly reduced CSFV and PCV2 viral loads in the serum and tissues compared to controls. <b>Conclusions</b>: These results demonstrate that a single dose of the PCV2/CSFV bivalent subunit vaccine is safe and effective in young pigs, induces strong antibody responses, and suppresses viral replication, making it a promising tool for swine disease control and cost-effective vaccination strategies.
format Article
id doaj-art-b825046e507f49e9a5280d0ec31eda96
institution Matheson Library
issn 2076-393X
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj-art-b825046e507f49e9a5280d0ec31eda962025-07-25T13:38:24ZengMDPI AGVaccines2076-393X2025-07-0113773610.3390/vaccines13070736Development of an Effective Single-Dose PCV2/CSFV Bivalent Subunit Vaccine Against Classical Swine Fever Virus and Porcine Circovirus Type 2Yu-Chieh Chen0Wen-Bin Chung1Hso-Chi Chaung2Yen-Li Huang3Chi-Chih Chen4Guan-Ming Ke5International Degree Program in Animal Vaccine Technology, National Pingtung University of Science and Technology, Pingtung 912301, TaiwanResearch Center for Animal Biologics, National Pingtung University of Science and Technology, Pingtung 912301, TaiwanResearch Center for Animal Biologics, National Pingtung University of Science and Technology, Pingtung 912301, TaiwanDepartment of Post-Baccalaureate Veterinary Medicine, Asia University, Taichung 413305, TaiwanResearch Center for Animal Biologics, National Pingtung University of Science and Technology, Pingtung 912301, TaiwanInternational Degree Program in Animal Vaccine Technology, National Pingtung University of Science and Technology, Pingtung 912301, Taiwan<b>Background/Objectives</b>: Porcine Circovirus Type 2 (PCV2) impairs pigs’ immune systems and increases susceptibility to co-infections, including Classical Swine Fever (CSF), a highly contagious disease listed by the World Organisation for Animal Health (WOAH) as notifiable. Therefore, swine operations in CSF-endemic regions are encouraged to immunize piglets with both PCV2 and CSFV vaccinations. Currently, there is no commercially available bivalent vaccine for PCV2/CSFV. <b>Methods</b>: In this study, a total of twenty 4-week-old SPF pigs were administered our formulated PCV2/CSFV bivalent subunit vaccine, containing soluble CSFV-E2 (50 µg) and PCV2-ORF2 (100 µg) antigens with a porcine-specific CpG adjuvant. After 4 weeks of vaccination, all pigs were evaluated for efficacy against PCV2 and CSFV. <b>Results</b>: Pigs were only immunized once and showed significantly increased neutralizing or ELISA antibody titers against both viruses four weeks post-vaccination. After viral challenges, vaccinated pigs displayed no clinical signs or lesions and had markedly reduced CSFV and PCV2 viral loads in the serum and tissues compared to controls. <b>Conclusions</b>: These results demonstrate that a single dose of the PCV2/CSFV bivalent subunit vaccine is safe and effective in young pigs, induces strong antibody responses, and suppresses viral replication, making it a promising tool for swine disease control and cost-effective vaccination strategies.https://www.mdpi.com/2076-393X/13/7/736Porcine circovirus type 2Classical swine feversingle dosebivalent subunit vaccine
spellingShingle Yu-Chieh Chen
Wen-Bin Chung
Hso-Chi Chaung
Yen-Li Huang
Chi-Chih Chen
Guan-Ming Ke
Development of an Effective Single-Dose PCV2/CSFV Bivalent Subunit Vaccine Against Classical Swine Fever Virus and Porcine Circovirus Type 2
Vaccines
Porcine circovirus type 2
Classical swine fever
single dose
bivalent subunit vaccine
title Development of an Effective Single-Dose PCV2/CSFV Bivalent Subunit Vaccine Against Classical Swine Fever Virus and Porcine Circovirus Type 2
title_full Development of an Effective Single-Dose PCV2/CSFV Bivalent Subunit Vaccine Against Classical Swine Fever Virus and Porcine Circovirus Type 2
title_fullStr Development of an Effective Single-Dose PCV2/CSFV Bivalent Subunit Vaccine Against Classical Swine Fever Virus and Porcine Circovirus Type 2
title_full_unstemmed Development of an Effective Single-Dose PCV2/CSFV Bivalent Subunit Vaccine Against Classical Swine Fever Virus and Porcine Circovirus Type 2
title_short Development of an Effective Single-Dose PCV2/CSFV Bivalent Subunit Vaccine Against Classical Swine Fever Virus and Porcine Circovirus Type 2
title_sort development of an effective single dose pcv2 csfv bivalent subunit vaccine against classical swine fever virus and porcine circovirus type 2
topic Porcine circovirus type 2
Classical swine fever
single dose
bivalent subunit vaccine
url https://www.mdpi.com/2076-393X/13/7/736
work_keys_str_mv AT yuchiehchen developmentofaneffectivesingledosepcv2csfvbivalentsubunitvaccineagainstclassicalswinefevervirusandporcinecircovirustype2
AT wenbinchung developmentofaneffectivesingledosepcv2csfvbivalentsubunitvaccineagainstclassicalswinefevervirusandporcinecircovirustype2
AT hsochichaung developmentofaneffectivesingledosepcv2csfvbivalentsubunitvaccineagainstclassicalswinefevervirusandporcinecircovirustype2
AT yenlihuang developmentofaneffectivesingledosepcv2csfvbivalentsubunitvaccineagainstclassicalswinefevervirusandporcinecircovirustype2
AT chichihchen developmentofaneffectivesingledosepcv2csfvbivalentsubunitvaccineagainstclassicalswinefevervirusandporcinecircovirustype2
AT guanmingke developmentofaneffectivesingledosepcv2csfvbivalentsubunitvaccineagainstclassicalswinefevervirusandporcinecircovirustype2